Skip to main content
Clinical Trials/ISRCTN23526619
ISRCTN23526619
Active, Not Recruiting
N/A

Evaluation of the clinical effectiveness and economic impact of a hybrid transdiagnostic cognitive behavioural treatment for persistent physical symptoms among adults seeking primary health care in Iceland: a randomized clinical trial

Reykjavík University0 sites29 target enrollmentAugust 3, 2021

Overview

Phase
N/A
Intervention
Not specified
Conditions
Not specified
Sponsor
Reykjavík University
Enrollment
29
Status
Active, Not Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 3, 2021
End Date
December 30, 2024
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
Reykjavík University

Eligibility Criteria

Inclusion Criteria

  • Current inclusion criteria as of 11/10/2022:
  • 1\. Referred to the study by primary care professionals between January 2022 and October 2022
  • 2\. Experience persistent physical symptoms that influence impairment in everyday life
  • 3\. Scoring above threshold on one of the following psychological measures: PHQ\-9, GAD\-7 or
  • 4\. Aged over 18 years of age
  • 5\. At assessment, say they will accept psychological treatment of their symptoms
  • Previous inclusion criteria:
  • 1\. Referred to VIRK for work rehabilitation between September 2021 and December 2022
  • 2\. Experience persistent physical symptoms which influence their workability
  • 3\. Scoring above threshold on one of the following psychological measures, PHQ\-9, GAD\-7 or SHAI

Exclusion Criteria

  • 1\. Do not speak/read Icelandic
  • 2\. Serious physical or mental health problems that affect participation in treatment, e.g. current psychotic symptoms, active substance abuse

Outcomes

Primary Outcomes

Not specified

Similar Trials